ACTG

ACTG is a global clinical trials network that conducts research to improve the management of HIV and its comorbidities; develop a cure for HIV; and innovate treatments for tuberculosis, hepatitis B, and emerging infectious diseases.

There are 15 currently enrolling trials across our research areas.

View All Trials

Our Areas of Research

HIV comorbidities & complications

4 enrolling trials

HIV cure

4 enrolling trials

COVID-19 and Mpox

2 enrolling trials

HIV treatment

2 enrolling trials

Tuberculosis

4 enrolling trials

Hepatitis

2 enrolling trials

Our Impact and Reach

Since our founding in 1987, ACTG investigators and sites across four continents have served as major resources for HIV and other infectious disease research, treatment, care, and education in their communities.

47k+

participants

sites

countries

3k+

trials

Voices for the Community

jankosmyna@gmail.com

Jan Kosmyna, MIS, B.Ed., RN

North Royalton, Ohio

Maureen Phiri

CAB member

Mandisa Jwara

CAB member

Roseline Swartz

CAB member

ANNOUNCEMENTS

ACTG CROI 2024 Presentations by Date and Time

08 March 2024

ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination

08 March 2024

ACTG Presents Study at CROI Demonstrating Efficacy of Long-Acting Injectable Treatment Among People Who Had Previously Been Unable to Maintain Viral Suppression on Daily Oral Medication

08 March 2024

LATEST NEWSLETTER

April 2024

Congratulations to Carlos del Rio, Charles Flexner from CROI, 2 milestones and 2 spotlights round out April's coverage.

Previous Issues

Red Ribbon Registry

The Red Ribbon Registry is a database of volunteers who are interested in participating in HIV/AIDS clinical trials.

Learn more here!